Hereditary Breast and Ovarian Cancer Syndrome Clinical Trial
Official title:
A Randomized Controlled Trial to Enhance the Use of Genetic Counseling and Testing in Latinas
The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. a FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial outcomes among Latinas at increased risk for hereditary breast and ovarian cancer (HBOC).
The investigators will conduct a two-arm RCT to evaluate the preliminary effectiveness of a culturally-adapted video developed by the team vs. FORCE fact sheet on enhancing genetic cancer risk assessment (GCRA; including genetic counseling and option for genetic testing) uptake and psychosocial outcomes among Latinas at increased risk for hereditary breast and ovarian cancer (HBOC). All participants will receive referrals to free telephone genetic counseling in Spanish to address cost, pragmatic, and language barriers. The investigators will recruit 28 Latina women at-risk of HBOC (14 randomized at each arm) at three sites with sizable Latinx populations. The sites include community clinics/health organizations and hospitals with whom we have established collaborations [Georgetown University (DC); Virginia Commonwealth University (VA)]. Results will improve efforts to translate genomic guidelines into practice and will reduce disparities by evaluating a low cost highly disseminable culturally-targeted video while gathering data on effectiveness and implementation. Aim 1. Evaluate the impact of video vs. FORCE fact sheet on GCRA and testing uptake and psychosocial outcomes. Aim 2. Assess implementation potential and needs by evaluating feasibility, acceptability, reach, and adoption of the intervention arms (video and FORCE fact sheet) and of the HBOC screening process at the community clinics. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00535119 -
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
|
Phase 1 | |
Recruiting |
NCT03294343 -
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
|
N/A | |
Completed |
NCT02956681 -
Statewide Communication to Reach Diverse Low Income Women
|
N/A | |
Completed |
NCT00305695 -
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
|
Phase 2 | |
Active, not recruiting |
NCT03832985 -
Pediatric Reporting of Adult-Onset Genomic Results
|
Early Phase 1 | |
Active, not recruiting |
NCT02760849 -
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
|
N/A | |
Recruiting |
NCT02653105 -
Women at Risk of Breast Cancer and OLFM4
|
N/A | |
Completed |
NCT01367639 -
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
|
Phase 2 | |
Completed |
NCT02562170 -
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
|
Phase 4 | |
Recruiting |
NCT03162276 -
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
|
Phase 3 | |
Not yet recruiting |
NCT01445275 -
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
|
N/A | |
Recruiting |
NCT03015376 -
Inherited Susceptible Genes Among Epithelial Ovarian Cancer
|
||
Enrolling by invitation |
NCT04197856 -
Direct Information to At-risk Relatives
|
N/A | |
Completed |
NCT03784859 -
Tissue Expansion in Breast Reconstruction Without Drains
|
||
Completed |
NCT00609505 -
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
|
N/A | |
Terminated |
NCT02705924 -
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
|
N/A | |
Completed |
NCT01333748 -
Search Allelic Imbalance of Expression of BRCA Genes in Hereditary Risk of Breast and/or Ovarian Cancer
|
Phase 2 | |
Completed |
NCT00892736 -
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
|
Phase 1 | |
Recruiting |
NCT05677048 -
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
|
N/A |